BackgroundImmune check point inhibitors (ICIs) are standard treatment for patients with non-small cell lung cancer (NSCLC).Nearly a decade has passed since nivolumab was approved by the FDA for NSCLC patients.However, long-term outcomes and clinical features callaway rogue ladies irons remain unclear for individual cases.Pseudo-progression is a wel
Martine Bordeleau,1,2 Guillaume callaway rogue ladies irons Léonard,1,2 Lynn Gauthier,3– 6 Catherine Estelle Ferland,7– 9 Miroslav Backonja,10,11 Jan Vollert,12– 15 Serge Marchand,2,16 Philip Jackson,17– 19 Léo Cantin,20,21 Michel Prud’Homme20,21 1Faculty of Medicine and Health Sciences, Université
Aims: The short QT syndrome type 1 (SQT1) is linked to hERG channel mutations (e.g., N588K).Drug effects on hERG channel gating kinetics in SQT1-cells have not been investigated.Methods: This study used hiPSC-CMs of a healthy chevy sonic rims for sale donor and a SQT1-patient carrying the N588K mutation and patch clamp to examine the drug effects o